University announces healthcare AI ‘cluster hires’

“Artificial intelligence in precision medical imaging and diagnostics” is among several areas of concentration for which the University of Wisconsin-Madison will be making cluster hires over a period of at least two years.

That time window represents an extension of the school’s normal start-and-end period for its cluster hires. These are made as a group across departments rather than individually within departments, according to an item posted by UW’s news division.

Other subjects greenlighted by the school for its latest cluster hires—the fourth round since it started the practice in 2018—include ethics in computing, data and information; exploring the origins of life across the galaxy; and breakthrough science with multi-messenger astrophysical data.

For the AI in precision medicine cluster hires, a leadership group will outline three key faculty positions that will be foundational to an expansion of UW-Madison’s leadership in the field.

“Next-generation medical imaging uses AI techniques to improve its diagnostic accuracy and predictive power, enabling advances in basic understanding of human disease, treatment monitoring and long-term surveillance of disease,” the description reads. “Collaborations like those forged by the cluster hire will contribute to the realization of the full potential of AI for precision medical imaging and diagnostics.”

Click here to read the rest of the item.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.